Dakota Wealth Management Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

Dakota Wealth Management purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 3rd quarter, HoldingsChannel reports. The firm purchased 617 shares of the company’s stock, valued at approximately $251,000.

Several other large investors also recently modified their holdings of the company. Jackson Wealth Management LLC bought a new position in shares of HCA Healthcare in the 3rd quarter worth about $282,000. YHB Investment Advisors Inc. acquired a new position in HCA Healthcare in the third quarter valued at approximately $268,000. International Assets Investment Management LLC grew its position in shares of HCA Healthcare by 40,544.0% during the 3rd quarter. International Assets Investment Management LLC now owns 20,322 shares of the company’s stock worth $82,590,000 after buying an additional 20,272 shares during the period. Commerzbank Aktiengesellschaft FI boosted its stake in HCA Healthcare by 25.5% during the third quarter. Commerzbank Aktiengesellschaft FI now owns 1,537 shares of the company’s stock worth $625,000 after acquiring an additional 312 shares in the last quarter. Finally, Weaver Capital Management LLC increased its stake in HCA Healthcare by 15.4% in the third quarter. Weaver Capital Management LLC now owns 2,614 shares of the company’s stock valued at $1,062,000 after purchasing an additional 349 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at HCA Healthcare

In other news, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the sale, the senior vice president now owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at approximately $3,436,623.54. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages recently commented on HCA. Royal Bank of Canada boosted their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. KeyCorp reduced their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday. Morgan Stanley began coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective on the stock. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Finally, Wells Fargo & Company increased their price objective on HCA Healthcare from $365.00 to $395.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 22nd. Five equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $379.11.

HCA Healthcare Trading Down 1.9 %

Shares of HCA stock opened at $356.63 on Tuesday. HCA Healthcare, Inc. has a 12-month low of $222.23 and a 12-month high of $417.14. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The company has a 50 day moving average of $394.71 and a 200-day moving average of $352.94. The firm has a market cap of $93.41 billion, a P/E ratio of 17.78, a PEG ratio of 1.52 and a beta of 1.67.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.74%. HCA Healthcare’s payout ratio is 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.